Buchumschlag

Similar usage of T‐cell receptor β‐chain between tumor and adjacent normal tissue in hepatocellular carcinoma

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Jie‐Zuan Yang, Shao‐Yan Xu, Dang‐Sheng Xiao, Jin‐You Li, Xiu‐Yuan Jin, Dong Yan
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Cancer Medicine
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy
von: Xiuyong Dang, et al.
Veröffentlicht: (2024)

Heterogeneity‐induced NGF‐NGFR communication inefficiency promotes mitotic spindle disorganization in exhausted T cells through PREX1 suppression to impair the anti‐tumor immunotherapy with PD‐1 mAb in hepatocellular carcinoma
von: Xin Wang, et al.
Veröffentlicht: (2024)

Roles of intralesional bacteria in the initiation and progression of oral squamous cell carcinoma
von: Zhuoyan Luo, et al.
Veröffentlicht: (2024)

Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma
von: Jie Hu, et al.
Veröffentlicht: (2024)

Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy
von: Sha She, et al.
Veröffentlicht: (2024)

Quercetin‐induced degradation of RhoC suppresses hepatocellular carcinoma invasion and metastasis
von: Chunlong Huang, et al.
Veröffentlicht: (2024)

Association between novel genetic variants of Notch signaling pathway genes and survival of hepatitis B virus‐related hepatocellular carcinoma
von: Liming Qin, et al.
Veröffentlicht: (2024)

Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma
von: Takahiro Kinami, et al.
Veröffentlicht: (2024)

Real world data of cabozantinib in patients with hepatocellular carcinoma: Focusing on dose setting and modification
von: Hironao Okubo, et al.
Veröffentlicht: (2024)

Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing
von: Linlin Zheng, et al.
Veröffentlicht: (2024)

Identification of pyroptosis subtypes and prognosis model of hepatocellular carcinoma based on pyroptosis‐related genes
von: Haisheng Xie, et al.
Veröffentlicht: (2024)

Correction to “The adverse characteristics of hepatocellular carcinoma in the non‐cirrhotic liver disproportionately disadvantage black patients”
Veröffentlicht: (2024)

Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein‐1 inhibitors: A promising treatment approach for high‐burden hepatocellular carcinoma
von: Shumin Fu, et al.
Veröffentlicht: (2024)

STEAP1 Suppresses Oral Squamous Cell Carcinoma by Targeting Wnt/β‐Catenin Signalling and EMT
von: Kuangyu Jin, et al.
Veröffentlicht: (2026)

CD2AP is a potential prognostic biomarker of renal clear cell carcinoma
von: Can Chen, et al.
Veröffentlicht: (2024)

A clinical‐radiomic‐pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection
von: Qu Xie, et al.
Veröffentlicht: (2024)

Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulants
von: Tasuku Nakabori, et al.
Veröffentlicht: (2024)

Risk factors for lenvatinib‐induced palmar‐plantar erythrodysesthesia syndrome in patients with hepatocellular carcinoma: A retrospective study
von: Shusuke Uekusa, et al.
Veröffentlicht: (2024)

A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese population
von: Yuanlin Zou, et al.
Veröffentlicht: (2024)

Toxicity profiles of immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta‐analysis
von: Shoutao Dang, et al.
Veröffentlicht: (2024)

Correction to “Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy”
Veröffentlicht: (2025)

Outcomes of hepatocellular carcinoma patients treated in the lenvatinib and immunotherapy era (2018–2021) compared to the sorafenib era (2008–2018)
von: Chloe A. Lim, et al.
Veröffentlicht: (2024)

Deep learning‐based accurate diagnosis and quantitative evaluation of microvascular invasion in hepatocellular carcinoma on whole‐slide histopathology images
von: Xiuming Zhang, et al.
Veröffentlicht: (2024)

An individualized stemness‐related signature to predict prognosis and immunotherapy responses for gastric cancer using single‐cell and bulk tissue transcriptomes
von: Linyong Zheng, et al.
Veröffentlicht: (2024)

Efficacy and prognostic factors of COVID‐19 vaccine in patients with hepatocellular carcinoma: Analysis of data from a prospective cohort study
von: He Zhao, et al.
Veröffentlicht: (2024)

Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study
von: Chao An, et al.
Veröffentlicht: (2024)

Exploring the factors affecting the occurrence of postoperative MVI and the prognosis of hepatocellular carcinoma patients treated with hepatectomy: A multicenter retrospective study
von: Jilin Yang, et al.
Veröffentlicht: (2024)

The m6A methyltransferase METTL5 promotes neutrophil extracellular trap network release to regulate hepatocellular carcinoma progression
von: Qi Wang, et al.
Veröffentlicht: (2024)

Anatomic versus non‐anatomic liver resection for hepatocellular carcinoma—A European multicentre cohort study in cirrhotic and non‐cirrhotic patients
von: Jasmin Zeindler, et al.
Veröffentlicht: (2024)

Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma
von: Qing Liu, et al.
Veröffentlicht: (2024)

The outcomes of different regimens depend on the molecular subtypes of pulmonary large‐cell neuroendocrine carcinoma: A retrospective study in China
von: Zhaojue Wang, et al.
Veröffentlicht: (2024)

Bioinformatics‐based identification of hepatocellular carcinoma‐associated hub genes and assessment of the restorative effect of tannic acid in rat liver exposed to monosodium glutamate
von: Hilal Tosun, et al.
Veröffentlicht: (2024)

Clinical factor‐based risk stratification for precision therapy in locally advanced squamous cell carcinoma of the uterine cervix
von: Feng‐Yuan Liu, et al.
Veröffentlicht: (2024)

Cell fusion between tumor cells and macrophages promotes the metastasis of OSCC patient through the activation of the chemokine signaling pathway
von: Chengwan Xia, et al.
Veröffentlicht: (2024)

Prevalence and prognosis of hypoxia‐inducible factor‐2α (HIF‐2α) pathway gene mutations across advanced solid tumors
von: Wenjun Zhong, et al.
Veröffentlicht: (2024)

Exosome‐related lncRNA score: A value‐based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma
von: Zhan Yang, et al.
Veröffentlicht: (2024)

Prevalence of neurotrophic tropomyosin receptor kinase ( NTRK ) fusion gene positivity in patients with solid tumors in Japan
von: Eiji Nakata, et al.
Veröffentlicht: (2024)

No lipiodol, no beads—another transcatheter arterial chemoembolization (TACE) with fine cisplatin powder and porous gelatin particles for TACE‐naïve, multifocal, up‐to‐seven out hepatocellular carcinoma
von: Rui Sato, et al.
Veröffentlicht: (2024)

Advances in research on factors affecting chimeric antigen receptor T‐cell efficacy
von: Delian Zhou, et al.
Veröffentlicht: (2024)

Prediction of prognosis in oral squamous cell carcinoma using infrared microspectroscopy
von: Conor A. Whitley, et al.
Veröffentlicht: (2024)